Hawthorne Health, Inc.
5 additional officers and directors
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- $2.48Msold on Form D
Filed a Form D on 23 Apr 2026: $2.48M sold on Form D. A Form D is an offering filing; it names no investors, stage or valuation.
A company that just raised has fresh capital, a new board and new vendors to choose.
- 1 investornamed
1 investor on record.
The investors already on the cap table shape who leads the next round.
- 8 directorsboard
8 directors on record from Form D filings and board-seat attributions.
The board is who decides on the next round and on a sale.
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 2
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 1
Financing history
- Apr 23, 2026Form D equity offering · $2.5M (form d sold) · 6 investorsFact Form D · “Hawthorne Health, Inc. filed Form D: $2,484,055 sold of $5,500,000, Other Health Care”
- Aug 26, 2025Form D equity offering · $10,707 (form d sold) · 1 investorFact Form D · “Hawthorne Health, Inc. filed Form D: $10,707 sold (indefinite offering), Other Health Care”
Investors on record
- Northpond Ventures, LLC board only, Lucy Coassin (strongly supported) Inference sec.gov
Ownership and outcomes
How these are wordedA company a buyout or growth firm lists on its own site is “listed in the portfolio of”, never “acquired by”. A date prints only when a deal record gives one; otherwise the row says when DFX first saw it.No firm portfolio page lists this company, so no outcome is stated.
Credit relationships
How a loan is matchedA BDC reports its loans by borrower name. A position shows here only when the match passed a precision gate (a hand-labelled sample was 29 of 30 correct); the tier and confidence are printed on each row. Amounts are the lender’s reported position, never a round.People
- Joshua Rose Executive Officer/Director sec.gov
- Lucy Coassin Resigned as director on 02/18/2026. Fact
- Lucy Coassin Resigned as director on 02/18/2026. Inference
- Jodi Akin Director Fact
Timeline
Evidence
Every observation on this company
- Entity type: Corporation Aug 13, 2026 Fact Form D
- Form D industry group: Aug 13, 2026 Fact Form D
- Amendment: false Aug 13, 2026 Fact Form D
- Revenue range (Form D): Decline to Disclose Aug 13, 2026 Fact Form D
- Incorporated: overFiveYears Aug 13, 2026 Fact Form D
- Jurisdiction: Delaware Aug 13, 2026 Fact Form D
- Amount sold (Form D): $10,707 Aug 13, 2026 Fact Form D
- Amount sold (Form D): $2.5M Aug 13, 2026 Fact Form D
- Offering amount (Form D): $5.5M Aug 13, 2026 Fact Form D
- Exemptions: 06b Aug 13, 2026 Fact Form D
- First sale: 2025-08-26 Aug 13, 2026 Fact Form D
- First sale: 2026-04-23 Aug 13, 2026 Fact Form D
- Indefinite offering: true Aug 13, 2026 Fact Form D
- Investors (Form D): 1 Aug 13, 2026 Fact Form D
- Investors (Form D): 6 Aug 13, 2026 Fact Form D
- Minimum investment (Form D): 0 Aug 13, 2026 Fact Form D
- Securities offered: option Aug 13, 2026 Fact Form D
- Securities offered: Debt, option Aug 13, 2026 Fact Form D
- Office address: Aug 13, 2026 Fact Form D
Record history
- Form D filed2026-08-13source on record
- Form D filed2026-08-13source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.